Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating

Nat Rev Drug Discov. 2021 Jan;20(1):3-5. doi: 10.1038/d41573-020-00217-7.
No abstract available

Publication types

  • News

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / immunology
  • Alzheimer Disease / metabolism
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology*
  • Humans
  • Phosphorylation
  • Treatment Failure
  • tau Proteins / antagonists & inhibitors*
  • tau Proteins / immunology
  • tau Proteins / metabolism

Substances

  • Antibodies, Monoclonal
  • tau Proteins